TheraRadar
← Back
Data updated: Mar 29, 2026

GLAND

OncologyCardiovascularInfectious Disease
Generics

GLAND is a generic drug manufacturer focused on Oncology, Cardiovascular, Infectious Disease. Key products include MIDAZOLAM IN 0.9% SODIUM CHLORIDE.

2013
Since
127
Drugs
-
Trials
906
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 34%
14 drugs
Cardiovascular 24%
10 drugs
Infectious Disease 20%
8 drugs
Respiratory 12%
5 drugs
Dermatology 10%
4 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...